SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-010250
Filing Date
2020-03-12
Accepted
2020-03-12 08:03:46
Documents
11
Period of Report
2020-03-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K agen-8k_20200312.htm 8-K 24705
2 EX-99.1 d859212dex991.htm EX-99.1 79290
3 EX-99.2 agen-ex992_6.htm EX-99.2 7164
4 GRAPHIC g859212logo.jpg GRAPHIC 13910
5 GRAPHIC grp32wxn55ph000002.jpg GRAPHIC 423244
6 GRAPHIC grp32wxn55ph000003.jpg GRAPHIC 306207
7 GRAPHIC grp32wxn55ph000001.jpg GRAPHIC 77366
8 GRAPHIC grp32wxn55ph000006.jpg GRAPHIC 261367
9 GRAPHIC grp32wxn55ph000005.jpg GRAPHIC 211936
10 GRAPHIC grp32wxn55ph000007.jpg GRAPHIC 54543
11 GRAPHIC grp32wxn55ph000004.jpg GRAPHIC 224389
  Complete submission text file 0001564590-20-010250.txt   2272779
Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address 3 FORBES ROAD LEXINGTON MA 02421 781-674-4410
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 20707205
SIC: 2836 Biological Products, (No Diagnostic Substances)